Comparison of propofol deep sedation versus moderate sedation during endosonography.

Digestive Diseases and Sciences
D S NayarF G Gress

Abstract

The purposes of this study are: (1) to prospectively evaluate clinically relevant outcomes including sedation-related complications for endoscopic ultrasound (EUS) procedures performed with the use of propofol deep sedation administered by monitored anesthesia care (MAC), and (2) to compare these results with a historical case-control cohort of EUS procedures performed using moderate sedation provided by the gastrointestinal (GI) endoscopist. Patients referred for EUS between January 1, 2001 and December 31, 2002 were enrolled. Complication rates for EUS using MAC sedation were observed and also compared with a historical case-control cohort of EUS patients who received meperidine/midazolam for moderate sedation, administered by the GI endoscopist. Logistic regression analysis was used to isolate possible predictors of complications. A total of 1,000 patients underwent EUS with propofol sedation during the period from January 1, 2001 through December 31, 2002 (mean age 64 years, 53% female). The distribution of EUS indications based on the primary area of interest was: 170 gastroduodenal, 92 anorectal, 508 pancreaticohepatobiliary, 183 esophageal, and 47 mediastinal. The primary endpoint of the study was development of sedation...Continue Reading

References

May 27, 1999·Gastrointestinal Endoscopy·R G Graber
Jul 14, 2000·The American Journal of Gastroenterology·G KoshyC S Pitchumoni
May 26, 2001·Gastrointestinal Endoscopy·D B NelsonUNKNOWN American Society for Gastrointestinal Endoscopy. Technology Committee
May 17, 2002·The American Journal of Gastroenterology·Douglas K RexDebra Helper
Oct 25, 2002·Gastrointestinal Endoscopy·Douglas O FaigelUNKNOWN Standards Practice Committe, American Society for Gastrointestinal Endoscopy
Apr 1, 2003·Gastrointestinal Endoscopy·Douglas O FaigelUNKNOWN Standards of Practice Committee. American Society for Gastrointestinal Endoscopy
Nov 26, 2003·The American Journal of Gastroenterology·Brian R WestonDouglas K Rex
Oct 22, 2008·Scandinavian Journal of Gastroenterology·Till Wehrmann, Andrea Riphaus
Dec 19, 2008·Digestion·Akira HoriuchiNaoki Tanaka
Jul 18, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Gregory A CotéSreenivasa S Jonnalagadda

❮ Previous
Next ❯

Citations

Jul 15, 2011·Therapeutics and Clinical Risk Management·Somchai AmornyotinSiriporn Kongphlay
Sep 25, 2012·World Journal of Gastroenterology : WJG·Christian JenssenSiegbert Faiss
Aug 8, 2013·World Journal of Gastroenterology : WJG·Can-Xia XuXiao-Ming Liu
Feb 6, 2013·World Journal of Gastroenterology : WJG·John K TriantafillidisApostolos E Papalois
Feb 21, 2013·World Journal of Gastrointestinal Endoscopy·Somchai Amornyotin
Jul 30, 2010·Digestive Diseases and Sciences·Lawrence B Cohen
Dec 21, 2013·Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society·Saurabh SethiMandeep S Sawhney
Oct 21, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Vaibhav WadhwaJohn J Vargo
Dec 1, 2017·World Journal of Gastrointestinal Endoscopy·Christian M AndradeGitanjali Vidyarthi
Nov 28, 2018·Current Medical Research and Opinion·Seho LimHyun Kang
Dec 10, 2013·Diseases of the Colon and Rectum·Adewunmi AdeyemoHarry Wasvary
Feb 18, 2017·World Journal of Gastroenterology : WJG·Jennifer Anne CampbellAndrew Derek Hopper
Feb 12, 2017·British Journal of Anaesthesia·S M GreenB S Krauss

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva
S Sáenz-LópezJ A Solís Herruzo
Gastrointestinal Endoscopy Clinics of North America
Lawrence B Cohen
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society
Tomofumi AkasakaNorio Hayashi
© 2021 Meta ULC. All rights reserved